A citation-based method for searching scientific literature

K Marder, H Zhao, R H Myers, M Cudkowicz, E Kayson, K Kieburtz, C Orme, J Paulsen, J B Penney, E Siemers, I Shoulson. Neurology 2000
Times Cited: 261







List of co-cited articles
650 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Huntington disease: clinical care and evaluation.
I Shoulson, S Fahn. Neurology 1979
571
21

Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
554
21

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Sarah J Tabrizi, Rachael I Scahill, Gail Owen, Alexandra Durr, Blair R Leavitt, Raymund A Roos, Beth Borowsky, Bernhard Landwehrmeyer, Chris Frost, Hans Johnson,[...]. Lancet Neurol 2013
511
21

Behavioral changes in Huntington Disease.
D Craufurd, J C Thompson, J S Snowden. Neuropsychiatry Neuropsychol Behav Neurol 2001
283
19

Huntington's disease.
Francis O Walker. Lancet 2007
18

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Sarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, Alexandra Durr, Blair Leavitt, Gail Owen, Rebecca Jones, Hans Johnson, David Craufurd, Stephen L Hicks,[...]. Lancet Neurol 2012
367
18

Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
562
18

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
958
17

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
Sarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, Raymund Ac Roos, Alexandra Durr, David Craufurd, Christopher Kennard, Stephen L Hicks, Nick C Fox, Rachael I Scahill,[...]. Lancet Neurol 2009
663
16

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Sarah J Tabrizi, Rachael I Scahill, Alexandra Durr, Raymund Ac Roos, Blair R Leavitt, Rebecca Jones, G Bernhard Landwehrmeyer, Nick C Fox, Hans Johnson, Stephen L Hicks,[...]. Lancet Neurol 2011
395
15

HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD).
N E Carlozzi, S G Schilling, J-S Lai, J S Paulsen, E A Hahn, J S Perlmutter, C A Ross, N R Downing, A L Kratz, M K McCormack,[...]. Qual Life Res 2016
34
44

"Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness.
Kevin Duff, Jane S Paulsen, Leigh J Beglinger, Douglas R Langbehn, Chiachi Wang, Julie C Stout, Christopher A Ross, Elizabeth Aylward, Noelle E Carlozzi, Sarah Queller. J Neuropsychiatry Clin Neurosci 2010
132
14

Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.
Kevin Duff, Jane S Paulsen, Leigh J Beglinger, Douglas R Langbehn, Julie C Stout. Biol Psychiatry 2007
272
13

Behavioural problems in Huntington's disease using the Problem Behaviours Assessment.
Elisabeth M Kingma, Erik van Duijn, Reinier Timman, Rose C van der Mast, Raymund A C Roos. Gen Hosp Psychiatry 2008
103
13

Neuropsychiatric aspects of Huntington's disease.
J S Paulsen, R E Ready, J M Hamilton, M S Mega, J L Cummings. J Neurol Neurosurg Psychiatry 2001
271
13

Neurocognitive signs in prodromal Huntington disease.
Julie C Stout, Jane S Paulsen, Sarah Queller, Andrea C Solomon, Kathryn B Whitlock, J Colin Campbell, Noelle Carlozzi, Kevin Duff, Leigh J Beglinger, Douglas R Langbehn,[...]. Neuropsychology 2011
255
13

Huntington's disease: a clinical review.
Raymund A C Roos. Orphanet J Rare Dis 2010
455
13

Indexing disease progression at study entry with individuals at-risk for Huntington disease.
Ying Zhang, Jeffrey D Long, James A Mills, John H Warner, Wenjing Lu, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2011
152
12

Preparing for preventive clinical trials: the Predict-HD study.
Jane S Paulsen, Michael Hayden, Julie C Stout, Douglas R Langbehn, Elizabeth Aylward, Christopher A Ross, Mark Guttman, Martha Nance, Karl Kieburtz, David Oakes,[...]. Arch Neurol 2006
236
12

Earliest functional declines in Huntington disease.
Leigh J Beglinger, Justin J F O'Rourke, Chiachi Wang, Douglas R Langbehn, Kevin Duff, Jane S Paulsen. Psychiatry Res 2010
89
13

Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
Erik van Duijn, David Craufurd, Anna A M Hubers, Erik J Giltay, Raphael Bonelli, Hugh Rickards, Karen E Anderson, Marleen R van Walsem, Rose C van der Mast, Michael Orth,[...]. J Neurol Neurosurg Psychiatry 2014
137
12


Psychopathology in verified Huntington's disease gene carriers.
E van Duijn, E M Kingma, R C van der Mast. J Neuropsychiatry Clin Neurosci 2007
185
11

Challenges assessing clinical endpoints in early Huntington disease.
Jane S Paulsen, Chiachi Wang, Kevin Duff, Roger Barker, Martha Nance, Leigh Beglinger, David Moser, Janet K Williams, Sheila Simpson, Douglas Langbehn,[...]. Mov Disord 2010
57
19

CAG repeat number governs the development rate of pathology in Huntington's disease.
J B Penney, J P Vonsattel, M E MacDonald, J F Gusella, R H Myers. Ann Neurol 1997
489
11

Behavioural abnormalities contribute to functional decline in Huntington's disease.
J M Hamilton, D P Salmon, J Corey-Bloom, A Gamst, J S Paulsen, S Jerkins, M W Jacobson, G Peavy. J Neurol Neurosurg Psychiatry 2003
123
11

Health-related quality of life in Huntington's disease: Which factors matter most?
Aileen K Ho, Abigail S Gilbert, Sarah L Mason, Anna O Goodman, Roger A Barker. Mov Disord 2009
93
11

Functional decline in Huntington's disease.
A Feigin, K Kieburtz, K Bordwell, P Como, K Steinberg, J Sotack, C Zimmerman, C Hickey, C Orme, I Shoulson. Mov Disord 1995
75
14

The neurology quality-of-life measurement initiative.
David Cella, Cindy Nowinski, Amy Peterman, David Victorson, Deborah Miller, Jin-Shei Lai, Claudia Moy. Arch Phys Med Rehabil 2011
132
11

Early Detection of Huntington Disease.
Jane S Paulsen. Future Neurol 2010
61
16

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
10


Depression and stages of Huntington's disease.
Jane S Paulsen, Carissa Nehl, Karin Ferneyhough Hoth, Jason E Kanz, Michelle Benjamin, Rachel Conybeare, Bradley McDowell, Beth Turner. J Neuropsychiatry Clin Neurosci 2005
143
9

Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
Guerry M Peavy, Mark W Jacobson, Jody L Goldstein, Joanne M Hamilton, Amy Kane, Anthony C Gamst, Stephanie L Lessig, J C Lee, Jody Corey-Bloom. Mov Disord 2010
68
13

Natural history of Huntington disease.
E Ray Dorsey, Christopher A Beck, Kristin Darwin, Paige Nichols, Alicia F D Brocht, Kevin M Biglan, Ira Shoulson. JAMA Neurol 2013
72
12

Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease.
Jennifer C Thompson, Jenny Harris, Andrea C Sollom, Cheryl L Stopford, Elizabeth Howard, Julie S Snowden, David Craufurd. J Neuropsychiatry Clin Neurosci 2012
112
9

Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.
Jane S Paulsen, Jeffrey D Long, Hans J Johnson, Elizabeth H Aylward, Christopher A Ross, Janet K Williams, Martha A Nance, Cheryl J Erwin, Holly J Westervelt, Deborah L Harrington,[...]. Front Aging Neurosci 2014
139
9

The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis.
Tamara Pringsheim, Katie Wiltshire, Lundy Day, Jonathan Dykeman, Thomas Steeves, Nathalie Jette. Mov Disord 2012
288
9

Tracking motor impairments in the progression of Huntington's disease.
Jeffery D Long, Jane S Paulsen, Karen Marder, Ying Zhang, Ji-In Kim, James A Mills. Mov Disord 2014
39
23

The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008.
David Cella, William Riley, Arthur Stone, Nan Rothrock, Bryce Reeve, Susan Yount, Dagmar Amtmann, Rita Bode, Daniel Buysse, Seung Choi,[...]. J Clin Epidemiol 2010
9

Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing.
Richard C Gershon, Jin Shei Lai, Rita Bode, Seung Choi, Claudia Moy, Tom Bleck, Deborah Miller, Amy Peterman, David Cella. Qual Life Res 2012
196
9

Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction.
Christopher A Ross, Alex Pantelyat, Jane Kogan, Jason Brandt. Mov Disord 2014
61
14

Factor analysis of behavioural symptoms in Huntington's disease.
Hugh Rickards, Jenny De Souza, Marleen van Walsem, Erik van Duijn, Sheila A Simpson, Ferdinando Squitieri, Bernhard Landwehrmeyer. J Neurol Neurosurg Psychiatry 2011
30
26

Psychiatric disorders in preclinical Huntington's disease.
Camille L Julien, Jennifer C Thompson, Sue Wild, Pamela Yardumian, Julie S Snowden, Gwen Turner, David Craufurd. J Neurol Neurosurg Psychiatry 2007
157
8

Psychiatric symptoms in neurologically asymptomatic Huntington's disease gene carriers: a comparison with gene negative at risk subjects.
G E Berrios, A C Wagle, I S Marková, S A Wagle, A Rosser, J R Hodges. Acta Psychiatr Scand 2002
65
12

Huntington's disease: clinical correlates of disability and progression.
N Mahant, E A McCusker, K Byth, S Graham. Neurology 2003
117
8

Rate of change in early Huntington's disease: a clinicometric analysis.
Christina Meyer, Bernhard Landwehrmeyer, Carsten Schwenke, Adam Doble, Michael Orth, Albert C Ludolph. Mov Disord 2012
15
53

The relationship between CAG repeat length and clinical progression in Huntington's disease.
Bernard Ravina, Megan Romer, Radu Constantinescu, Kevin Biglan, Alicia Brocht, Karl Kieburtz, Ira Shoulson, Michael P McDermott. Mov Disord 2008
62
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.